NEWHALL CHARLES W III 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 27, 2024
Insider Transaction Report
Form 4
NEWHALL CHARLES W III
Director
Transactions
- Award
Common Stock
2024-02-23+3,886→ 120,975 total - Disposition to Issuer
Restricted Stock Unit
2024-02-23−3,886→ 0 total→ Common Stock (3,886 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F2]These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024.